SAM
CERE

Silphium Asset Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Silphium Asset Management’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-123,314
Closed -$5.04M – 61
2024
Q2 		$5.04M Buy
+123,314
New +$5.14M 2.4% 10

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Silphium Asset Management's CERE Position: Q3 2024 in Review

Silphium Asset Management sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 123,314 shares — an estimated $5.04M sold.

Silphium Asset Management first reported a position in CERE in Q2 2024 and held it in 1 quarter. The position peaked at $5.04M in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Silphium Asset Management reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Silphium Asset Management sold 123,314 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $5.04M.
  • Silphium Asset Management first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2024 and held it in 1 quarter.
  • Silphium Asset Management's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $5.04M in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Silphium Asset Management's 13F filing for Q3 2024, filed 30 Jan 2025.